|
Health Technology Assessment: critical in reaching favourable pricing and reimbursement decisions
|
For delegates
Health technology assessment is a critical tool used by health agencies across the globe in order to assess the efficiency of new pharmaceutical products by linking the drugs impact to defined outcomes. It has become the single most important appraisal in order to achieve market access and reimbursement status.
As a result, Health Network Communications, in association with the London School of Economics is organising the first annual policy forum for the industry where all the major HTA agencies across the world and leading pharmaceutical pharmaceutical companies discuss the challenges in obtaining market access.
|
All Health Technology Assessment professionals under 1 roof
|
|
Our speakers
The Health Technology Assessment World Europe is the meeting point for heads of departments in all Industry areas of Health Economics and Outcomes Research. Senior decision makers will meet with Regulatory and HTA Bodies, and clients to form mutually beneficial relationships in an open forum.
» Take a look at this years speakers
» Register now
|
For sponsors
If promoting your services and products to senior personnel working in health economics, outcomes research, pharmaceutical pricing and reimbursement is a priority to you, than there can be no better forum, than this important and influential event in the pharmaceutical calendar.
» Networking opportunities
|
Optimising pharmacoeconomics and outcomes research
Areas to be discussed include:
- Review of HTA methodologies across the globe
- How do you demonstrate cost benefit?
- How do you collect and process patient reported outcomes (PRO’s)?
- How do you integrate outcomes research into commercial decisions?
- What economic modelling techniques should you be using and when?
These topics will be addressed by HTA leaders from, NICE, CADTH, Blue Cross Blue Shield, HAS, LFN, CVZ, Scottish Medicines Consortium, Danish Centre for Health Technology Assessment, CAHTAR, German Agency for HTA, plus industry representatives from GlaxoSmithKline, Pfizer, Merck and AIFA.
» Find out more
» Looking for an event taking place sooner or in a different part of the world?
|
